Vasculitis and Giant Cell Arteritis

Top Story

Adalimumab yields superior outcomes vs. infliximab in Behçet’s-related uveitis

July 9, 2019
In the JournalsPerspective

Steroid use in polymyalgia, GCA linked to significantly higher infection risk

June 24, 2019
Th use of oral steroids in patients with polymyalgia rheumatica or giant cell arteritis is associated with a significant increase in the risk for infection, with higher…
Feature

Social media opens new avenue to advocacy in rheumatology

June 21, 2019
Political activism is more accessible than ever thanks to the amplification offered by social media, and rheumatologists can use social media — particularly…
Meeting NewsVideo

Patients with suspected GPA should be assessed for cardiac involvement

May 28, 2019
DESTIN, Fla. — It is important for rheumatologists to assess for possible cardiac manifestations among patients with suspected granulomatosis with polyangiitis…
More Headlines »
CME ABIM MOC

Ace the Case: A 73-Year-Old Woman With Abrupt Onset of Transient Left-Sided Diplopia

There is no commercial support for this activity.

This educational activity will utilize a case study to assess the diagnosis and management of a 73-year-old woman with…
More »
Video
Meeting News Coverage

VIDEO: A look at tocilizumab for treatment of giant cell arteritis

July 7, 2016
More »
CME

Multidisciplinary Perspectives in Giant Cell Arteritis: A Team-based Approach for Improved Quality of Care

This activity is supported by an educational grant from Genentech, Inc.

Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. If left untreated, patients…
More »